The Cancer Biology, Informatics & Omics (CBIO) training program in the School of Medicine (SOM) at the University of California, San Diego (UCSD) provides graduate students and post-doctoral scholars with training in discovery cancer research that is directly relevant to the nation's goal of lessening the burden of cancer. The proposed training is based on three rationales: (i) Advancements in cancer diagnosis and treatment are propelled by basic research discoveries on cancer-relevant biological processes; (ii) Cancer omics data, combined with omics studies in model organisms, can and will accelerate the discovery of new and cancer- relevant gene functions and pathways; and (iii) Modern investigation of cancer biology in the human system requires proficiency in omics technologies and computational tools. Based on these rationales, the CBIO training curriculum is designed to (a) achieve research excellence in advanced systems and approaches, (b) provide foundation knowledge on cancer biology and bioinformatics, (c) develop translational insights through Tumor Boards at the Moores Cancer Center (MCC), (d) keep pace with advancements through seminars, workshops, national conferences, and (e) foster a collaborative community through program meetings and retreats. With an emphasis on big data collection and analysis, the CBIO program aims to prepare the next generation of leaders to accelerate the pace of cancer discovery and to advance the delivery of precision cancer medicine. The CBIO program selects faculty preceptors with cancer-relevant research expertise, productive research programs, principled research conduct and outstanding training history from the Departments of Cellular & Molecular Medicine, Medicine, Pathology, Pediatrics, Pharmacology and Surgery. CBIO also develops junior faculty co-mentors to update the research expertise and to ensure continuity of the program. CBIO selects predoc trainees with outstanding academic achievements and cancer-relevant thesis projects from PhD students in the Biomedical Sciences graduate program. Previous predoc trainees have established productive careers as faculty and research scientists in the public and the private sectors. In the latest funding period, training has been extended to post-doc scholars focused on cancer research. Moving forward, CBIO will provide individualized and tailored training and career development to postdocs with PhDs in biological sciences, bioengineering, or computer sciences. An Executive Committee, consisting of Program Director, Co-Directors, a faculty preceptor with global cancer research perspectives and two UCSD leaders in diversity enhancement, will select and evaluate trainees and faculty. An External Advisory Committee will review program metrics annually to identify strengths and weaknesses of training activities, trainees and faculty. An Internal Advisory Committee consisting of leaders in the SOM and MCC will provide guidance on program planning and development. Through its activities, CBIO will serve as a hub for big data research and training in cancer biology, cancer computational biology and cancer omics technology in the UCSD School of Medicine.

Public Health Relevance

Advancements in basic, translational and clinical cancer research have culminated in the dawn of precision cancer medicine that delivers genomics-informed and pathway-targeted therapies with enhanced efficacy and reduced toxicity. However, critical gaps in the basic knowledge of cancer biology have limited the success of precision cancer medicine to a subset of tumors and patients. To fill the gaps in knowledge and to develop the technologies and computational tools in big data collection and analyses, the Cancer Biology, Informatics & Omics (CBIO) program provides training in the diversity of systems and approaches that must be employed to investigate the complex biology of cancer and to drive further advancements in precision cancer medicine.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA067754-23
Application #
9698304
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Lim, Susan E
Project Start
1995-09-25
Project End
2022-06-30
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
23
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of California, San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Khaliullin, Renat N; Green, Rebecca A; Shi, Linda Z et al. (2018) A positive-feedback-based mechanism for constriction rate acceleration during cytokinesis in Caenorhabditis elegans. Elife 7:
Aznar, Nicolas; Ear, Jason; Dunkel, Ying et al. (2018) Convergence of Wnt, growth factor, and heterotrimeric G protein signals on the guanine nucleotide exchange factor Daple. Sci Signal 11:
Nussbacher, Julia K; Yeo, Gene W (2018) Systematic Discovery of RNA Binding Proteins that Regulate MicroRNA Levels. Mol Cell 69:1005-1016.e7
Hatcher, John M; Wu, Guowei; Zeng, Chuyue et al. (2018) SRPKIN-1: A Covalent SRPK1/2 Inhibitor that Potently Converts VEGF from Pro-angiogenic to Anti-angiogenic Isoform. Cell Chem Biol 25:460-470.e6
Lee, Kian-Yong; Green, Rebecca A; Gutierrez, Edgar et al. (2018) CYK-4 functions independently of its centralspindlin partner ZEN-4 to cellularize oocytes in germline syncytia. Elife 7:
Santaguida, Stefano; Richardson, Amelia; Iyer, Divya Ramalingam et al. (2017) Chromosome Mis-segregation Generates Cell-Cycle-Arrested Cells with Complex Karyotypes that Are Eliminated by the Immune System. Dev Cell 41:638-651.e5
Benitez, Jorge A; Ma, Jianhui; D'Antonio, Matteo et al. (2017) PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3. Nat Commun 8:15223
Ly, Peter; Teitz, Levi S; Kim, Dong H et al. (2017) Selective Y centromere inactivation triggers chromosome shattering in micronuclei and repair by non-homologous end joining. Nat Cell Biol 19:68-75
Weng, S; Matsuura, S; Mowery, C T et al. (2017) Restoration of MYC-repressed targets mediates the negative effects of GM-CSF on RUNX1-ETO leukemogenicity. Leukemia 31:159-169
Aznar, Nicolas; Kalogriopoulos, Nicholas; Midde, Krishna K et al. (2016) Heterotrimeric G protein signaling via GIV/Girdin: Breaking the rules of engagement, space, and time. Bioessays 38:379-93

Showing the most recent 10 out of 57 publications